Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
essential hypertension
MeSH D000075222 - essential hypertension
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D006973:
Hypertension
241 Companies
96 Drugs
$
Success rate
D000075222:
Â
Essential hypertension
2 Companies
3 Drugs
$
Success rate
D000092244:
Isolated systolic hypertension
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Allergan
Telmisartan
,
Hydrochlorothiazide
Â
ActelsarÂ
Â
2013-03-13Â
Â
Â
Nova Laboratories
Spironolactone
Â
QaialdoÂ
Â
2023-05-26Â
Â
Â
Clinical Trials
Historical Success Rate
Phase 1
62
%
16/26
Phase 2
66
%
19/29
Phase 3
71
%
20/28
Approved:
1
Overall Success rate:
29%
All Clinical Trials
No data
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use